Home/Pipeline/Respiratory Portfolio

Respiratory Portfolio

Respiratory Diseases

Not DisclosedActive

Key Facts

Indication

Respiratory Diseases

Phase

Not Disclosed

Status

Active

Company

Phargentis

About Phargentis

Phargentis is a Swiss virtual biopharma company, founded in 2015, specializing in complex generics and SuperGenerics with a current focus on respiratory diseases. Operating as part of the Chemholding SA group, it leverages a capital-efficient, virtual model by outsourcing development and partnering for commercialization. Its strategy is built on securing API supply from its sister company, Cerbios-Pharma, and licensing out mature products to global pharma partners for distribution.

View full company profile

Therapeutic Areas

Respiratory Diseases Oncology

Other Respiratory Diseases Drugs

Drug	Company	Phase	Status
Inhalation APIs	ChemWerth	Approved	Commercial
Synthetic VLP Vaccines	nCage Therapeutics	Pre-clinical	Active
Not specifically disclosed on public website	Taisho Pharmaceutical	Various	Active
QX031N	Qyuns Therapeutics	Preclinical	Active